Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
05/2003
05/15/2003US20030092067 Libraary of enzyme inhibitor or use in the treatment of cancer and parasitic disease
05/15/2003US20030091587 Bactericides, fungicides, viricides
05/15/2003CA2466328A1 Isotopically coded affinity markers 3
05/15/2003CA2464736A1 Beta-secretase inhibitors and methods of use
05/14/2003EP1310507A2 Novel peptide nucleic acids
05/14/2003EP1310482A1 Prodrugs of excitatory amino acids
05/14/2003EP1309869A1 Designing and screening random libraries of compounds
05/14/2003EP1309613A2 Pharmaceutical composition comprising an analgesic peptide
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP0846682B9 Penicillaminamide derivatives
05/14/2003EP0783319B1 Muramyl peptide compositions for inhibiting hiv replication
05/14/2003EP0550450B1 Use of crosslinked crystals as a novel form of enzyme immobilization
05/14/2003CN1418112A Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
05/13/2003US6562852 Streptogramin derivatives, their preparation and compositions which contain them
05/13/2003US6562848 For treating HIV infection, comprising: administering claimed compound with at least one compound selected from the group consisting of HIV reverse transcriptase inhibitors and HIV protease inhibitors
05/13/2003US6562789 Histidine derivatives, preparation process, and their use as free antiradical agents
05/13/2003US6562787 Hybrid polypeptides with enhanced pharmacokinetic properties
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562590 Controlling biological pests; generate genetically engineered microorganism, expose to insect pests, monitor effect on insect propagation
05/13/2003CA2096933C Compounds and compositions which inhibit bone resorption
05/08/2003WO2003037933A2 Dermopharmaceutically and cosmetically active oligopeptides
05/08/2003WO2003037917A1 Tumor antigen
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037912A2 Tri-, tetra-, and penta-peptides having antiangiogenic activity
05/08/2003WO2003037269A2 Di-, tri,- and tetra-peptides having antiangiogenic activity
05/08/2003WO2003037266A2 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2002014542A3 Process for detecting serine/threonine kinase activity
05/08/2003US20030088119 Catalyst modification to enhance neotame production
05/08/2003US20030088097 E.g., tert-butyloxycarbonyl-protected 2-(2,2,2-trifluoroethyl)hexahydroimidazo(1,5-a)pyrazine
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087921 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
05/08/2003US20030087832 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis
05/08/2003US20030087831 1,3,4-Oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
05/08/2003US20030087828 Peptide derivatives and pharmaceutically acceptable salts, thereof, processes for preparation of both, and use thereof
05/08/2003US20030087407 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
05/08/2003US20030087379 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
05/08/2003CA2466326A1 Tri-, tetra-, and penta-peptides having antiangiogenic activity
05/08/2003CA2466306A1 Di-, tri,- and tetra-peptides having antiangiogenic activity
05/08/2003CA2466152A1 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003CA2465639A1 Tumor antigen
05/08/2003CA2465123A1 Dermopharmaceutically and cosmetically active oligopeptides
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/07/2003EP1307472A1 Peptides capable of functioning as mimotopes for estradiol analytes
05/07/2003EP1307214A1 Highly homogeneous molecular markers for electrophoresis
05/07/2003EP1095036B1 Cinnamic acid derivatives as cell adhesion molecules
05/07/2003EP0998470B1 Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003CN1107668C Process for preparing alpha, omega, delta-tribenzyloxycarbonyl arginine
05/06/2003US6559334 Polymers chromatographic separation of enantiomers
05/06/2003US6559280 Controlling protein levels in eucaryotic organisms
05/06/2003US6559127 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/06/2003US6559126 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
05/06/2003US6558649 Vitronectin receptor antagonist pharmaceuticals
05/06/2003CA2032864C Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
05/02/2003EP1305798A2 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition
05/02/2003EP1056704B1 Antitumor agents
05/02/2003EP0728196B1 Mutants of a thermostable neutral protease from bacillus
05/01/2003WO2003035675A1 Biologically active peptides and their use for repairing injured nerves
05/01/2003WO2003035674A1 Crystal of oxidized glutathione and process for producing the same
05/01/2003WO2003035060A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
05/01/2003WO2003035055A1 Mch antagonists for the treatment of obesity
05/01/2003WO2003026575A3 Molecules specific for npff receptors and uses thereof
05/01/2003WO2002010124A3 Salt forms of an hiv protease inhibitor
05/01/2003US20030083356 Statine derivatives for the treatment of Alzheimer's disease
05/01/2003US20030083266 Administering N-acetyl cysteine ethyl ester for prophylaxis of stroke and trauma
05/01/2003US20030083263 Pentapeptide compounds and uses related thereto
05/01/2003US20030083237 Anti-angiogenic peptides for cancer treatment
05/01/2003US20030083236 Myelopeptides and their therapeutic use
05/01/2003CA2462163A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
04/2003
04/30/2003CN1414971A Depsipeptide and congeners thereof for use as immunosuppressants
04/30/2003CN1106800C 甜味料组合物 Sweetener composition
04/29/2003US6555692 Polylactams having imidazole or pyrrole rings specifically bind with subnanomolar affinity to a predetermined DNA sequence; use in molecular biology and diagnostic medicine; gene expression control; target the minor groove of B-form
04/29/2003US6555570 Growth hormone secretagogous with improved bioavailability
04/29/2003US6555339 Altering human G protein-coupled receptors (GPCRs) by point mutation; use in drug screening
04/29/2003US6555091 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses
04/29/2003CA2121369C Inhibitors of dipeptidyl-aminopeptidase type iv
04/24/2003WO2003033525A1 Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
04/24/2003WO2003033524A2 Peptidyl ketones as inhibitors of dpiv
04/24/2003WO2003033523A2 Cytotoxic compounds
04/24/2003WO2003032918A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
04/24/2003WO2002036798A3 Inhibitors of transglutaminases
04/24/2003WO2002022553A3 Non-natural basic amino acids, their preparation and use
04/24/2003WO2002016408A3 Gpe analogs
04/24/2003WO2001098540A3 Recombination modulators and methods for their production and use
04/24/2003US20030078369 Apicidin-derived cyclic tetrapeptides
04/24/2003US20030078247 Enzyme inhibitor of a dipeptidyl peptidase for treating hyperglycaemia
04/24/2003US20030078211 Compositions and methods for inhibiting bone resorption
04/24/2003US20030077334 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanism for normal and transformed cells
04/24/2003CA2463729A1 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
04/24/2003CA2461170A1 Peptidyl ketones as inhibitors of dpiv
04/23/2003EP1304327A2 Glutamine-thiazolidide and -pyrrolidide and their use as dipeptidylpeptidase IV inhibitors
04/23/2003EP1304322A2 Carboxylic acid compound and use thereof
04/23/2003EP1303538A2 Ghrelin antagonists
04/23/2003EP1303534A2 Promyostatin peptides and methods of using same
04/23/2003EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
04/23/2003EP1303491A1 Thrombin inhibitors comprising an aminoisoquinoline group
04/23/2003EP1303487A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
04/23/2003EP1140982B1 Synthesis and recovery of aspartame involving enzymatic deformylation step
04/23/2003EP1082314B1 New dipeptidyl peptidase iv effectors
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 307